Grant Number:	5R03CA143975-02 Interpret this number
Primary Investigator:	Rodriguez Zas, Sandra
Organization:	University Of Illinois At Urbana-Champaign
Project Title:	Discovery of Exon, Microrna and Clinical Prognostic Markers of Glioblastoma Survi
Fiscal Year:	2010

DESCRIPTION (provided by applicant): Abstract More than 10,000 people per year in the United States are diagnosed with Glioblastoma multiforme, the most common primary brain tumor, and the median survival (irrespective of therapy) is one year. The multifactorial nature of this disease and limited scope of previous studies has resulted in an incomplete understanding of the etiology of glioblastoma survival. The main goal of this application is to augment the knowledge on the prognostic markers and determinants of glioblastoma survival. The conceptual framework encompasses the simultaneously consideration clinical and genomic information, use of a large sample size including 397 glioblastoma and matched control samples, and a comprehensive analysis of the relationship between glioblastoma survival and the explanatory variables using frailty models. Specific Aim 1 centers on the detection of exon expression and clinical prognostic markers of glioblastoma survival meanwhile, Specific Aim 2 entails the uncovering of microRNA expression markers together with exon expression and clinical markers. Exon and microRNA-centric and gene-centric approaches to model the genomic information will be pursued. To address the high-dimensionality of the proposed study, a combination of feature extraction strategies will be implemented. A mixed-effects proportional hazards model that accommodates for heterogeneity of variances and correlation between observations will be used to model glioblastoma survival. The posterior density estimates obtained from a Bayesian Markov chain Monte Carlo approach will offer a complete characterization of the associations between the prognostic markers and survival. Calibration of the survival predictive equation will use cross-validation approaches and benchmarking to known markers of glioblastoma survival. This application addresses several high-priority areas in cancer epidemiology research that have been identified by the NCI and our group has prior experience on the foundations of the proposed study. The outcomes of this study will be 1) the identification of clinical and genomic prognostic markers of glioblastoma survival acting independently, synergistically or antagonistically, 2) the characterization of changes in survival associated with these markers, 3) development of a more universal prediction or prognostic index of glioblastoma survival, 4) identification of glioblastoma subclasses corresponding to particular combinations of clinical and genomic levels, and 5) understanding of the interplay between a wide range of clinical and genomic factors with the ultimate goal of elucidating the etiology of cancer. The results from the proposed multi-factorial analysis of glioblastoma genomic and clinical data will support the effective design of functional molecular studies of cancer survival, facilitate the exchange of discoveries between the basic sciences and clinical and public health practice and lead to biomedical strategies to diagnose, prevent, treat and cure cancer. PUBLIC HEALTH RELEVANCE: Project Narrative This project will uncover clinical and genomic prognostic markers and determinants of glioblastoma survival. The outcomes of this study include the enhanced understanding of the interplay between multiple clinical and genomic variables with the ultimate goals of elucidating the etiology of cancer and development of a reliable survival prediction function. These findings will facilitate functional molecular studies, the exchange of discoveries between the basic sciences and clinical and public health practice and the development of biomedical strategies to diagnose, prevent, treat and cure cancer.




Transcription Factor-microrna-target Gene Networks Associated With Ovarian Cancer Survival And Recurrence
Authors: Delfino K.R. , Rodriguez-Zas S.L. .
Source: Plos One, 2013; 8(3), p. e58608.
PMID: 23554906
Related Citations

Microarray Analysis Of Natural Socially Regulated Plasticity In Circadian Rhythms Of Honey Bees
Authors: Rodriguez-Zas S.L. , Southey B.R. , Shemesh Y. , Rubin E.B. , Cohen M. , Robinson G.E. , Bloch G. .
Source: Journal Of Biological Rhythms, 2012 Feb; 27(1), p. 12-24.
PMID: 22306970
Related Citations

First Survey And Functional Annotation Of Prohormone And Convertase Genes In The Pig
Authors: Porter K.I. , Southey B.R. , Sweedler J.V. , Rodriguez-Zas S.L. .
Source: Bmc Genomics, 2012; 13, p. 582.
PMID: 23153308
Related Citations

Identification And Characterization Of Alternative Exon Usage Linked Glioblastoma Multiforme Survival
Authors: Sadeque A. , Serão N.V. , Southey B.R. , Delfino K.R. , Rodriguez-Zas S.L. .
Source: Bmc Medical Genomics, 2012; 5, p. 59.
PMID: 23206951
Related Citations

Therapy-, Gender- And Race-specific Microrna Markers, Target Genes And Networks Related To Glioblastoma Recurrence And Survival
Authors: Delfino K.R. , Serão N.V. , Southey B.R. , Rodriguez-Zas S.L. .
Source: Cancer Genomics & Proteomics, 2011 Jul-Aug; 8(4), p. 173-83.
PMID: 21737610
Related Citations

Transferase Activity Function And System Development Process Are Critical In Cattle Embryo Development
Authors: Adams H.A. , Southey B.R. , Everts R.E. , Marjani S.L. , Tian C.X. , Lewin H.A. , Rodriguez-Zas S.L. .
Source: Functional & Integrative Genomics, 2011 Mar; 11(1), p. 139-50.
PMID: 20844914
Related Citations

Cell Cycle And Aging, Morphogenesis, And Response To Stimuli Genes Are Individualized Biomarkers Of Glioblastoma Progression And Survival
Authors: Serão N.V. , Delfino K.R. , Southey B.R. , Beever J.E. , Rodriguez-Zas S.L. .
Source: Bmc Medical Genomics, 2011; 4, p. 49.
PMID: 21649900
Related Citations

Discovery Of Gene Network Variability Across Samples Representing Multiple Classes
Authors: Ko Y. , Zhai C. , Rodriguez-Zas S.L. .
Source: International Journal Of Bioinformatics Research And Applications, 2010; 6(4), p. 402-17.
PMID: 20940126
Related Citations